|
12
|
58
|
4znxA |
Crystal structure of the fyn-sh3 domain in complex with the high affinity peptide app12 |
|
86
|
269
|
4yjsA |
The kinase domain of human spleen tyrosine (syk) in complex with gtc000226 |
|
90
|
266
|
4y95A |
Crystal structure of the kinase domain of bruton's tyrosine kinase with mutations in the activation loop |
|
85
|
270
|
4yjvA |
The kinase domain of human spleen tyrosine (syk) in complex with gtc000250 |
|
82
|
269
|
4yc8A |
C-helix-out binding of dasatinib analog to c-abl kinase |
|
87
|
270
|
4yjrA |
Syk kinase domain in complex with inhibitor gtc000225 |
|
28
|
167
|
4y94A |
Crystal structure of the ph-th module of bruton's tyrosine kinase bound to inositol hexakisphosphate |
|
85
|
270
|
4yjqA |
Syk kinase domain in complex with inhibitor gtc000224 |
|
85
|
273
|
4xg2A |
Crystal structure of ligand-free syk |
|
63
|
254
|
4xz1A |
Zap-70-tsh2:compound-b adduct |
|
105
|
444
|
4xi2A |
Crystal structure of an auto-inhibited form of bruton's tryrosine kinase |
|
84
|
272
|
4xg3A |
Crystal structure of an inhibitor-bound syk |
|
90
|
274
|
4xg6A |
Crystal structure of an inhibitor-bound syk |
|
83
|
270
|
4xg9A |
Crystal structure of an inhibitor-bound syk |
|
56
|
136
|
4xefA |
Pyk2-fat complexed with leupaxin ld motif ld1 |
|
79
|
268
|
4xliA |
Crystal structure of abl2/arg kinase in complex with dasatinib |
|
80
|
270
|
4xg8A |
Crystal structure of an inhibitor-bound syk |
|
86
|
273
|
4xg4A |
Crystal structure of an inhibitor-bound syk |
|
64
|
155
|
4xevA |
Fusion of pyk2-fat domain with leupaxin ld1 motif, complexed with leupaxin ld4 peptide |
|
84
|
273
|
4xeyA |
Crystal structure of an sh2-kinase domain construct of c-abl tyrosine kinase |
|
70
|
258
|
4xz0A |
Zap-70-tsh2:compound-a complex |
|
86
|
273
|
4xg7A |
Crystal structure of an inhibitor-bound syk |
|
60
|
137
|
4xekA |
Pyk2-fat domain in complex with leupaxin ld4 motif |
|
77
|
269
|
4wa9A |
The crystal structure of human abl1 wild type kinase domain in complex with axitinib |
|
106
|
331
|
4umtA |
Structure of melk in complex with inhibitors |
|
76
|
283
|
4v0gB |
Jak3 in complex with a covalent egfr inhibitor |
|
76
|
282
|
4v0gA |
Jak3 in complex with a covalent egfr inhibitor |
|
87
|
290
|
4wovA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with bms-066 aka 2-methoxy-n-({6-[3-methyl-7-(methylamino)-3,5,8,10-tetraazatricyclo[7.3.0.0, 6]dodeca-1(9),2(6),4,7,11-pentaen-11-yl]pyridin-2-yl}methy l)acetamide |
|
93
|
290
|
4wnmA |
Syk catalytic domain in complex with a potent triazolopyridine inhibitor |
|
95
|
329
|
4umqA |
Structure of melk in complex with inhibitors |
|
91
|
277
|
4rx9A |
Syk catalytic domain complexed with a potent pyrimidine inhibitor |
|
16
|
61
|
4rtzA |
Crystal structure of the c-src-sh3 domain in complex with the high affinity peptide vsl12 |
|
79
|
275
|
4u5jA |
C-src in complex with ruxolitinib |
|
13
|
57
|
4rtvA |
Crystal structure of the src tyrosine kinase sh3 domain s94a/q128r mutant in complex with the high affinity synthetic peptide app12 |
|
26
|
110
|
4tziA |
Structure of unliganded lyn sh2 domain |
|
84
|
271
|
4twpA |
The crystal structure of human abl1 t315i gatekeeper mutant kinase domain in complex with axitinib |
|
26
|
113
|
4u1pA |
Human fyn-sh2 domain in complex with a synthetic high-affinity phospho-peptide |
|
89
|
275
|
4rx8A |
Syk catalytic domain complexed with a potent triazine inhibitor2 |
|
75
|
266
|
4ueuA |
Tyrosine kinase as - a common ancestor of src and abl |
|
21
|
102
|
4u17A |
Swapped dimer of the human fyn-sh2 domain |
|
87
|
271
|
4rssA |
Crystal structure of tyrosine-protein kinase syk with an inhibitor |
|
90
|
275
|
4rx7A |
Syk catalytic domain complexed with a potent triazine inhibitor |
|
11
|
58
|
4rtyA |
Crystal structure of the c-src-sh3 domain in complex with the high affinity peptide app12 |
|
37
|
163
|
4u5wB |
Crystal structure of hiv-1 nef-sf2 core domain in complex with the src family kinase hck sh3-sh2 tandem regulatory domains |
|
94
|
263
|
4rfzA |
Crystal structure of btk kinase domain complexed with 6-(dimethylamino)-8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]isoquinolin-1-one |
|
89
|
263
|
4rg0A |
Crystal structure of btk kinase domain complexed with 2-[8-fluoro-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(4-methylpiperazin-1-yl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-1-oxo-3,4-dihydroisoquinolin-6-yl]-2-methyl-propanenitrile |
|
6
|
57
|
4rtuA |
Crystal structure of the intertwined form of the src tyrosine kinase sh3 domain t96g/q128r mutant |
|
90
|
263
|
4rfyA |
Crystal structure of btk kinase domain complexed with 6-(dimethylamino)-2-[2-(hydroxymethyl)-3-[1-methyl-5-[[5-(morpholine-4-carbonyl)-2-pyridyl]amino]-6-oxo-3-pyridyl]phenyl]-3,4-dihydroisoquinolin-1-one |
|
90
|
285
|
4rioA |
Crystal structure of jak3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor |
|
55
|
132
|
4r32A |
Crystal structure analysis of pyk2 and paxillin ld motifs |
